Endothelin receptor antagonists : status quo and future perspectives for targeted therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Journal of Clinical Medicine (9:3) - Basel : MDPI - S. 1-29
In: http://www.mdpi.com/journal/jcm
- Ereignis
-
Veröffentlichung
- (wo)
-
Magdeburg
- (wer)
-
Universitätsbibliothek Otto-von-Guericke-Universität
- (wann)
-
2020
- Urheber
-
Enevoldsen, Frederik C.
Sahana, Jayashree
Wehland, Markus
Grimm, Daniela Gabriele
Infanger, Manfred
Krüger, Marcus
- DOI
-
10.25673/36436
- URN
-
urn:nbn:de:gbv:ma9:1-1981185920-366687
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:44 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Enevoldsen, Frederik C.
- Sahana, Jayashree
- Wehland, Markus
- Grimm, Daniela Gabriele
- Infanger, Manfred
- Krüger, Marcus
- Universitätsbibliothek Otto-von-Guericke-Universität
Entstanden
- 2020
Ähnliche Objekte (12)
Novel GRPR-targeted antagonists with improved pharmacokinetics for imaging and therapy of GRPR-expressing malignancies
Targeted cancer therapy
Irreversible Antagonists for the Adenosine A2B Receptor
Evaluation of Neurotensin Receptor-1 Antagonists as Potential Radiotracers for the Therapy of Pancreatic Adenocarcinoma
Targeted Therapy beim Nierenzellkarzinom
Multivalently binding antagonists for the neurokinin-1 receptor
Transferrin receptor targeted gene delivery
Advances in targeted cancer therapy
Targeted Therapy in der Rheumatologie
Signal transduction and targeted therapy
Anticonvulsant effects of isomeric nonimidazole histamine H3 receptor antagonists
Structure-Based Development of Selective Orexin 1 Receptor Antagonists
Novel GRPR-targeted antagonists with improved pharmacokinetics for imaging and therapy of GRPR-expressing malignancies
Targeted cancer therapy
Irreversible Antagonists for the Adenosine A2B Receptor
Evaluation of Neurotensin Receptor-1 Antagonists as Potential Radiotracers for the Therapy of Pancreatic Adenocarcinoma
Targeted Therapy beim Nierenzellkarzinom
Multivalently binding antagonists for the neurokinin-1 receptor
Transferrin receptor targeted gene delivery
Advances in targeted cancer therapy
Targeted Therapy in der Rheumatologie
Signal transduction and targeted therapy
Anticonvulsant effects of isomeric nonimidazole histamine H3 receptor antagonists
Structure-Based Development of Selective Orexin 1 Receptor Antagonists
Novel GRPR-targeted antagonists with improved pharmacokinetics for imaging and therapy of GRPR-expressing malignancies
Targeted cancer therapy
Irreversible Antagonists for the Adenosine A2B Receptor
Evaluation of Neurotensin Receptor-1 Antagonists as Potential Radiotracers for the Therapy of Pancreatic Adenocarcinoma
Targeted Therapy beim Nierenzellkarzinom
Multivalently binding antagonists for the neurokinin-1 receptor
Transferrin receptor targeted gene delivery
Advances in targeted cancer therapy
Targeted Therapy in der Rheumatologie
Signal transduction and targeted therapy
Anticonvulsant effects of isomeric nonimidazole histamine H3 receptor antagonists